11/09/2024
Alliance Cinema’s New Non-Profit PIP Media Launches Production of Groundbreaking Cancer Documentary "The C-Story".
Directed by award-winning filmmaker Jim Milio ("Rescue 911") and produced by Jeanette Milio ("The Experiment"), this powerful new documentary explores cutting-edge treatments and scientific breakthroughs in the fight against cancer.
PIP Media, Alliance Cinema’s newly launched 501(c)(3) non-profit, has commenced production in Europe on “The C-Story,” a compelling documentary dedicated to illuminating the latest advancements in cancer treatment and research.
Led by Emmy-nominated director Jim Milio, the film aims to educate and inspire cancer patients and their families by showcasing transformative developments in oncology.
“We’re grateful to the world-renowned experts who have shared their invaluable insights into the latest treatment options and pioneering research," says Jeanette Milio. "Their contributions will offer hope and informed options to millions affected by cancer."
Esteemed contributors include:
• Prof. Dr. Matthias Preusser, Professor and Head of the Clinical Division of Oncology, Medical University of Vienna
• Prof. Dr. Fabrice Andre, Medical Oncologist and Head of Research, Gustave Roussy, Université Paris-Saclay
• Prof. Dr. Nathalie Albert, Senior Physician, Nuclear Medicine, LMU University Hospital, Munich
• Prof. Dr. Wieland Voigt, Managing Director, VOC-Advanced Breath Diagnostics GmbH, Erlangen & Forchheim
• Dr. Christian R. Becker, CEO and Medical Director at MUX in Munich-Starnberg, and Helen Becker, MUX Co-Founder
• Prof. Dr. Giovanni Apolone, Scientific Director, Foundation IRCCS Istituto Nazionale dei Tumori, Milan
These leaders, alongside upcoming interviews with experts from the United States, Asia, and Australia, provide crucial perspectives on groundbreaking innovations, personalized therapies, and the future of cancer treatment.
Through "The C-Story," PIP Media is committed to amplifying the voices of these scientific trailblazers, offering factual, hope-filled insights to those impacted by cancer around the world.